about
The possibility of clinical sequencing in the management of cancerIdentifying priority medicines policy issues for New Zealand: a general inductive study.Rare cancers: Challenges & issues.Integration of cancer genomics with treatment selection: from the genome to predictive biomarkersRare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.The PI3K Pathway in Human Disease.Somatic mutations in salivary duct carcinoma and potential therapeutic targets.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.
P2860
Q28072144-45299E33-2719-497D-B4DC-83A813E23B7AQ33691338-AE3E7706-9579-401D-9293-53F968F7C9D5Q33768543-B660D3B0-2B7D-4A9B-A36A-4BDBB1143633Q37595614-1DCEB9A6-5DC2-42B3-8705-543123A229EFQ46182953-F4504A89-EEE3-445E-AEED-6DF848AD0D16Q46546002-04F3822F-3123-48D1-902C-729D1B765A1DQ47133482-C122071F-3D5C-43A6-B74A-18919A52982AQ52363678-01799753-3E1F-44C3-9ECC-EB421648FF1F
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted therapy in rare cancers--adopting the orphans.
@en
type
label
Targeted therapy in rare cancers--adopting the orphans.
@en
prefLabel
Targeted therapy in rare cancers--adopting the orphans.
@en
P2860
P1476
Targeted therapy in rare cancers--adopting the orphans.
@en
P2093
Javier Munoz
P2860
P304
P356
10.1038/NRCLINONC.2012.160
P407
P577
2012-09-11T00:00:00Z